FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us

Resources

  • Videos
  • Research Reports
  • FAQ

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
QuantRx Biomedical Corporation Stock AnalysisComprehensive stock analysis for QuantRx Biomedical Corporation (QTXB) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisQTXB
QTXB
QuantRx Biomedical Corporation
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
QTXB
Home🔹Stocks🔹QuantRx Biomedical Corporation

QuantRx Biomedical Corporation

QTXB•OTC

QuantRx Biomedical Corporation

QTXB•OTC
Market cap
$118.05K
Sentiment

Your view on QTXB

Mkt Cap
$118.05K
Sentiment
Your view
QTXB
QuantRx Biomedical Corporation
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
QTXB
Company Overview

Overview

What the company does, where it operates, and who runs it.

About QuantRx Biomedical Corporation

Industry
Medical - Instruments & Supplies
Sector
Healthcare
CEO
Shalom Z. Hirschman
Headquarters
10190 SW 90th Avenue, Tualatin, OR, US
Industry
Medical - Instruments & Supplies
Sector
Healthcare
CEO
Shalom Z. Hirschman
Headquarters
10190 SW 90th Avenue, Tualatin, OR, US
Description

QuantRx Biomedical Corporation engages in the development and commercialization of patented miniform pads (PADs) and PAD based over-the-counter products in the United States. It is also developing genomic diagnostics for the laboratory market based on its lateral flow patents, including RapidSense technology, a one-step lateral flow test. The company's PAD products are used for the treatment of hemorrhoids, minor vaginal infection, urinary incontinence, general catamenial uses, and other medical needs. Its products include InSync, a feminine hygienic interlabial pad; Unique miniform, a treated pad for the temporary relief of the itch and discomfort associated with hemorrhoids and minor vaginal infection, as well as an untreated pad for the daily protection of light urinary, vaginal, or anal leakage; and other treated miniform products. QuantRx Biomedical Corporation was incorporated in 1986 and is based in Tualatin, Oregon.

Infographics

Visual summary of the business at a glance.

FRC Research

Media

Videos and interviews covering the company.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks the stock is worth vs. the current price.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Peer Comparison

Comparables

List of peer companies in the same industry.

Ownership & News

Institutional Ownership

Which funds and firms own the stock.

Insider Trading

Recent buying and selling by company executives.

Senate Trading

U.S. Senator disclosures filed under the STOCK Act.

News

Latest headlines and market coverage.

News

Latest Market News